MA30629B1 - Derives de pyrazole servant d'inhibiteurs du cytochrome p450 - Google Patents

Derives de pyrazole servant d'inhibiteurs du cytochrome p450

Info

Publication number
MA30629B1
MA30629B1 MA31618A MA31618A MA30629B1 MA 30629 B1 MA30629 B1 MA 30629B1 MA 31618 A MA31618 A MA 31618A MA 31618 A MA31618 A MA 31618A MA 30629 B1 MA30629 B1 MA 30629B1
Authority
MA
Morocco
Prior art keywords
cytochrome
inhibitors
pyrazole derivatives
solvates
salts
Prior art date
Application number
MA31618A
Other languages
English (en)
Inventor
Simon Paul Planken
Scott Channing Sutton
Rongliang Chen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA30629B1 publication Critical patent/MA30629B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dérivés de pyrazole servant d'inhibiteurs du cytochrome p450 La présente invention propose des composés de formule (I) ou leurs sels ou produits de solvatation, des procédés pour leur préparation, des méthodes pour leur utilisation, et des formulations pharmaceutiques les contenant.
MA31618A 2006-07-05 2009-02-05 Derives de pyrazole servant d'inhibiteurs du cytochrome p450 MA30629B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80659606P 2006-07-05 2006-07-05
US91098807P 2007-04-10 2007-04-10
US94180807P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
MA30629B1 true MA30629B1 (fr) 2009-08-03

Family

ID=38515807

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31618A MA30629B1 (fr) 2006-07-05 2009-02-05 Derives de pyrazole servant d'inhibiteurs du cytochrome p450

Country Status (24)

Country Link
US (1) US7919488B2 (fr)
EP (1) EP2046774A1 (fr)
KR (1) KR20090034958A (fr)
CN (1) CN101511812A (fr)
AP (1) AP2009004763A0 (fr)
AR (1) AR062154A1 (fr)
AU (1) AU2007270814B2 (fr)
CA (1) CA2660031A1 (fr)
CO (1) CO6150178A2 (fr)
CR (1) CR10573A (fr)
EA (1) EA200900135A1 (fr)
GT (1) GT200700053A (fr)
IL (1) IL196490A0 (fr)
MA (1) MA30629B1 (fr)
MX (1) MX2009000482A (fr)
NO (1) NO20090346L (fr)
NZ (1) NZ574207A (fr)
PE (1) PE20080998A1 (fr)
RS (1) RS20090036A (fr)
TN (1) TN2009000033A1 (fr)
TW (1) TWI334867B (fr)
UY (1) UY30460A1 (fr)
WO (1) WO2008004096A1 (fr)
ZA (1) ZA200900478B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8754107B2 (en) * 2006-11-17 2014-06-17 Abbvie Inc. Aminopyrrolidines as chemokine receptor antagonists
WO2008112022A1 (fr) * 2007-03-13 2008-09-18 Arete Therapeutics, Inc. Inhibiteurs de l'époxyde hydrolase soluble
US8242145B2 (en) 2008-02-14 2012-08-14 Panmira Pharmaceuticals, Llc Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
US8426449B2 (en) 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
DE102008057364A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057344A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung
DE102009041242A1 (de) 2009-09-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
DE102009041241A1 (de) 2009-09-11 2011-08-04 Bayer Schering Pharma Aktiengesellschaft, 13353 Substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057343A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
TWI582091B (zh) 2010-06-30 2017-05-11 艾諾屋製藥公司 可溶性鳥苷酸環化酶（ｓＧＣ）刺激物
ES2572803T3 (es) 2010-11-09 2016-06-02 Ironwood Pharmaceuticals, Inc. Estimuladores de GCs
US9139564B2 (en) 2011-12-27 2015-09-22 Ironwood Pharmaceuticals, Inc. 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
CN104540813A (zh) * 2012-06-27 2015-04-22 默沙东公司 磺酰胺衍生物以及使用它们用于改善药物的药物动力学的方法
WO2014000178A1 (fr) 2012-06-27 2014-01-03 Merck Sharp & Dohme Corp. Dérivés de sulfamide et leurs méthodes d'utilisation permettant d'améliorer la pharmacocinétique d'un médicament
WO2014194519A1 (fr) * 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Dérivés imidazole et leurs procédés d'utilisation pour l'amélioration des propriétés pharmacocinétiques d'un médicament
WO2015070366A1 (fr) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Dérivés d'imidazole et de triazole liés à aryle et leurs procédés d'utilisation pour améliorer la pharmacocinétique d'un médicament
WO2015070367A1 (fr) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Dérivés d'imidazole et de triazole liés à la pipéridine ou la pipérazine et leurs procédés d'utilisation pour améliorer la pharmacocinétique d'un médicament
US20220144797A1 (en) * 2019-02-08 2022-05-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
PT1373263E (pt) * 2001-04-05 2005-03-31 Torrent Pharmaceuticals Ltd Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas
US7008953B2 (en) * 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US7662844B2 (en) * 2004-07-12 2010-02-16 Osi Pharmaceuticals, Inc. Naphthylene derivatives as cytochrome P450 inhibitors
AU2006293605B2 (en) 2005-09-23 2011-05-19 Pfizer Products Inc. Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome P450 3A4 (CYP3A4)

Also Published As

Publication number Publication date
GT200700053A (es) 2009-08-03
EA200900135A1 (ru) 2009-06-30
CR10573A (es) 2009-02-12
WO2008004096A1 (fr) 2008-01-10
EP2046774A1 (fr) 2009-04-15
TN2009000033A1 (fr) 2010-08-19
KR20090034958A (ko) 2009-04-08
ZA200900478B (en) 2010-04-28
NZ574207A (en) 2010-10-29
AR062154A1 (es) 2008-10-22
IL196490A0 (en) 2011-07-31
AP2009004763A0 (en) 2009-02-28
CO6150178A2 (es) 2010-04-20
CN101511812A (zh) 2009-08-19
RS20090036A (en) 2010-06-30
TWI334867B (en) 2010-12-21
US7919488B2 (en) 2011-04-05
AU2007270814B2 (en) 2011-07-14
MX2009000482A (es) 2009-01-27
AU2007270814A1 (en) 2008-01-10
CA2660031A1 (fr) 2008-01-10
UY30460A1 (es) 2008-02-29
NO20090346L (no) 2009-02-19
TW200811159A (en) 2008-03-01
PE20080998A1 (es) 2008-08-15
US20080021011A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
MA30629B1 (fr) Derives de pyrazole servant d'inhibiteurs du cytochrome p450
MA29791B1 (fr) Composes therapeutiques.
MA31419B1 (fr) Derives de pyridine
TNSN07022A1 (fr) Derives de pyridine
MA32965B1 (fr) Derives de sulfonamides
MA29926B1 (fr) Derives de pyrazine
MA27560A1 (fr) Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation
MA27559A1 (fr) Nouveaux derives de fluorglycoside aromatiques, produits pharmaceutiques contenant ces composes et leur utilisation
MY148634A (en) Pyridazinone derivatives
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
MA30076B1 (fr) Carbonylaminopyrrolopyrazoles servant de puissants inhibiteurs de kinases.
TN2011000454A1 (fr) Derives de benzofurannyle utilises comme inhibiteurs de glucokinase
MA30784B1 (fr) Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs.
MA30487B1 (fr) Nouveaux composes heterocycliques
MA31754B1 (fr) Cis-imidazolines chirales
MA28270A1 (fr) Pyrido [2, 3-D] pyrimidine-2, 4-diamines servant d'inhibiteurs de PDE 2
MA31683B1 (fr) Composes et procedes pour moduler fxr
MA30428B1 (fr) Derives de dihydropyrazolopyrimidinones
MA29839B1 (fr) Derives de carboxamides servant d'antagonistes des recepteurs muscariniques
MA32171B1 (fr) Compose heterocyclique
MA31586B1 (fr) Dérivés d'alcools alkyliques de 1-phényl-2-pyridinyle en tant qu'inhibiteurs de la phosphodiestérase
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
TNSN05202A1 (fr) Indolone-oxazolidinones antibacteriennes, intermediaires pour leur preparation et compositions pharmaceutiques les contenant
TN2009000028A1 (fr) Agonistes de ep2
MA29160B1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine